Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bourel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Comptes Rendus Biologies|April 29, 2006
[Monoclonal antibodies: technology around the clock for new therapeutic hopes]Dominique Bourel, Jean-Luc Teillaud
Revue De Synthese|October 16, 2016
Dominique Bourel, Pierre-François Moreau, Michel Peterson
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 16, 2003
Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseasesMartine Bruley-Rosset, Luc Mouthon, Youri Chanseaud, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Immunology Letters|May 4, 2012
Effect of zinc on human IgG1 and its FcγR interactionsSophie Sibéril, Renée Ménez, Sylvie Jorieux, et al.
Revue De Synthese|October 16, 2016
Jean-Pierre Cléro, Régis Morelon, Dominique Bourel, et al.
British Journal of Haematology|February 19, 2008
A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodiesRoland Beliard, Tony Waegemans, Dominique Notelet, et al.
Clinical Immunology (Orlando, Fla.)|December 8, 2005
Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functionsSophie Sibéril, Christophe de Romeuf, Nicolas Bihoreau, et al.
British Journal of Haematology|February 28, 2008
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16Christophe de Romeuf, Charles-Antoine Dutertre, Magali Le Garff-Tavernier, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Comptes Rendus Biologies|April 29, 2006
[Monoclonal antibodies: technology around the clock for new therapeutic hopes]Dominique Bourel, Jean-Luc Teillaud
Revue De Synthese|October 16, 2016
Dominique Bourel, Pierre-François Moreau, Michel Peterson
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 16, 2003
Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseasesMartine Bruley-Rosset, Luc Mouthon, Youri Chanseaud, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Immunology Letters|May 4, 2012
Effect of zinc on human IgG1 and its FcγR interactionsSophie Sibéril, Renée Ménez, Sylvie Jorieux, et al.
Revue De Synthese|October 16, 2016
Jean-Pierre Cléro, Régis Morelon, Dominique Bourel, et al.
British Journal of Haematology|February 19, 2008
A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodiesRoland Beliard, Tony Waegemans, Dominique Notelet, et al.
Clinical Immunology (Orlando, Fla.)|December 8, 2005
Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functionsSophie Sibéril, Christophe de Romeuf, Nicolas Bihoreau, et al.
British Journal of Haematology|February 28, 2008
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16Christophe de Romeuf, Charles-Antoine Dutertre, Magali Le Garff-Tavernier, et al.
Pageof 1